Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)
NCT00385307
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
680
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
amibegron (SR58611A)
Sponsor
Sanofi